Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Kokoh Exa Nusantara Tbk (KOCI) Price & Performance

Indofarma Tbk.Trade
Kokoh Exa Nusantara TbkTrade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Kokoh Exa Nusantara Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Kokoh Exa Nusantara Tbk trades at Rp134 (market cap 576.31B, 60.42M 24h volume). The key difference: Kokoh Exa Nusantara Tbk is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFKOCI
Market Cap
390.51B576.31B
Volume
60.42M
Lot
604.22K
Turnover
7.95B
Average Price
131.63
Value
7.95B
Indicative Equilibrium Price
134
Indicative Equilibrium Volume
5.59K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
KOCI
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Kokoh Exa Nusantara Tbk

PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.

Read more on KOCI